Literature DB >> 16330021

Repeated electroconvulsive stimuli increase brain-derived neurotrophic factor in ACTH-treated rats.

Bingjin Li1, Katsuya Suemaru, Ranji Cui, Yoshihisa Kitamura, Yutaka Gomita, Hiroaki Araki.   

Abstract

Electroconvulsive therapy is considered to be an effective treatment for severe depression. We have already shown that the antidepressant-like effects of tricyclic antidepressants in the rat forced swim test are blocked by repeated treatment with adrenocorticotropic hormone (ACTH). In the present study, we investigated the effect of repeated electroconvulsive stimuli on the forced swim test and on brain-derived neurotrophic factor (BDNF) protein levels in ACTH-treated rats. Electroconvulsive stimuli (50 mA, 0.2 s) was administered 30 min after ACTH treatment (100 microg/rat, s.c.) once daily for 14 days. In both saline and ACTH-treated rats, repeated electroconvulsive stimuli for 6 or 14 days decreased the immobility time in the forced swim test and increased the BDNF protein levels in the hippocampus. However, repeated imipramine administration (10 mg/kg, i.p. for 14 days) had no effect on the hippocampus BDNF protein levels in ACTH-treated rats. These results suggest that electroconvulsive stimuli has decreasing effects of immobility time in the forced swim test in the tricyclic antidepressant-resistant depressive model of rats induced by repeated ACTH treatment, and that increased BDNF may be involved in this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330021     DOI: 10.1016/j.ejphar.2005.11.009

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.

Authors:  Gislaine Zilli Réus; Airam Barbosa de Moura; Laura Araújo Borba; Helena Mendes Abelaira; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2019-05-21

2.  Pharmacokinetic and pharmacodynamic studies of drug interaction following oral administration of imipramine and sodium alginate in rats.

Authors:  Shinichi Watanabe; Katsuya Suemaru; Naoto Inoue; Kimie Imai; Tachio Aimoto; Hiroaki Araki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-01       Impact factor: 3.000

3.  Dissociative changes in gray matter volume following electroconvulsive therapy in major depressive disorder: a longitudinal structural magnetic resonance imaging study.

Authors:  Hui Xu; Teng Zhao; Feifei Luo; Yunsong Zheng
Journal:  Neuroradiology       Date:  2019-08-13       Impact factor: 2.804

Review 4.  Rodent models of treatment-resistant depression.

Authors:  Barbara J Caldarone; Venetia Zachariou; Sarah L King
Journal:  Eur J Pharmacol       Date:  2014-11-21       Impact factor: 4.432

5.  Asenapine modulates mood-related behaviors and 5-HT1A/7 receptors-mediated neurotransmission.

Authors:  Sarah Delcourte; Erika Abrial; Adeline Etiévant; Renaud Rovera; Jørn Arnt; Michael Didriksen; Nasser Haddjeri
Journal:  CNS Neurosci Ther       Date:  2017-04-17       Impact factor: 5.243

6.  Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice.

Authors:  BingJin Li; Yosefu Arime; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Eur J Pharmacol       Date:  2009-11-22       Impact factor: 4.432

7.  The mechanism of acute fasting-induced antidepressant-like effects in mice.

Authors:  Ranji Cui; Jie Fan; Tongtong Ge; Linda Tang; Bingjin Li
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

8.  Narp Mediates Antidepressant-Like Effects of Electroconvulsive Seizures.

Authors:  Andrew D Chang; Punit V Vaidya; Edward P Retzbach; Sunho J Chung; Urian Kim; Kathryn Baselice; Kristen Maynard; Alec Stepanian; Melissa Staley; Lan Xiao; Ashley Blouin; Sungho Han; JongAh Lee; Paul F Worley; Kellie L Tamashiro; Barbara L Hempstead; Keri Martinowich; Mary Ann Wilson; Jay M Baraban; Irving M Reti
Journal:  Neuropsychopharmacology       Date:  2017-10-20       Impact factor: 8.294

Review 9.  Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature.

Authors:  M Polyakova; M L Schroeter; B M Elzinga; S Holiga; P Schoenknecht; E R de Kloet; M L Molendijk
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

Review 10.  The Effects of Calorie Restriction in Depression and Potential Mechanisms.

Authors:  Yifan Zhang; Changhong Liu; Yinghao Zhao; Xingyi Zhang; Bingjin Li; Ranji Cui
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.